Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Habitual abortion or recurrent pregnancy loss (RPL) is the occurrence of repeated pregnancies that end in miscarriage of the fetus, usually before 20 weeks of gestation. RPL affects about 0.34% of women who conceive.
Habitual abortion (recurrent pregnancy loss or recurrent miscarriage) is the occurrence of 3 consecutive spontaneous miscarriages (spontaneous abortions). The majority (85%) of women who have had two miscarriages will conceive and carry normally afterwards, so statistically the occurrence of three abortions at 0.34% is regarded as "habitual".
There are various causes for habitual abortions, and some are treatable. Some couples never have a cause identified, often after extensive investigations.
An uterine malformation is considered to cause about 15% of recurrent miscarriages. The most common abnormality is a uterine septum, a partition of the uterine cavity. The diagnosis is made by x-ray or ultrasound of the uterus. Also uterine leiomyomata could result to pregnancy loss.
A balanced translocation or Robertsonian translocation in one of the partners leads to unviable fetuses that are aborted spontaneously. This explains why a karyogram is often performed in both partners if a woman has suffered repeated abortions. About 3% of the time a chromosomal problem of one or both partners can lead to recurrent pregnancy loss. Although patients which such a chromosomal problem are more likely to miscarriage, they can also deliver normal or abnormal babies.
Women with thyroid disorders, both hypo- or hyperactivity, have are at increased risk for pregnancy losses. Unrecognized or poorly treated diabetes mellitus leads to increased miscarriages. Women with polycystic ovary syndrome also have higher loss rates possibly related to hyperinsulinemia or excess androgens. Inadequate production of progesterone in the luteal phase may set the stage for RPL (see below).
An important example is the increased risk of abortion in women with thrombophilia (propensity for blood clots). The most common problem is the factor V Leiden and prothrombin G20210A mutation. Recent studies confirm that anticoagulant medication may improve the chances of carrying pregnancy to term. It explains about 15% of recurrent miscarriages.
Increased uterine NK cellsEdit
A controversial area is the presence of increased natural killer cells in the uterus. It is poorly understood whether these cells actually inhibit the formation of a placenta, and it has been noted that they might be essential for this process. A 2004 paper (Moffett et al) warned that determination of NK cells in peripheral blood does not predict uterine NK cell numbers, because they are a different class of lymphocytes, and state that immunosuppressive treatments are not warranted.
Parental HLA sharingEdit
Earlier studies that perhaps paternal sharing of HLA genes would be associated with increased pregnancy loss have not been confirmed.
Reduced ovarian reserveEdit
The risk for miscarriage increases with age, and women in the advanced reproductive age who have a reduced ovarian reserve are prone to higher risk of repeated miscarriages. Such miscarriages are due to decreased egg quality .
Luteal phase defectEdit
The issue of a luteal phase defect is complex. The theory behind the concept suggests that an inadequate amount of progesterone is produced by the corpus luteum to maintain the early pregnancy. Assessment of this situation was traditionally carried out by an endometrial biopsy, however recent studies have not confirmed that such assessment is valid. Studies about the value of progesterone supplemenation remain deficient, however, such supplementation is commonly carried out on an empirical basis.
While lifestyle factors have been associated with increased risk for miscarriage in general, and are usually not listed as specific causes for RPL, every effort should be made to address these issues in patients with RPL. Of specific concern are chronic exposures to toxins including smoking, alcohol, and drugs.
A number of maternal infections can lead to a single pregnancy loss, including listeriosis, toxoplasmosis, and certain viral infections (rubella, herpes simplex, measles, cytomegalo virus, coxsackie virus). However, there are no confirmed studies to suggest that specific infections will lead to recurrent pregnancy loss in humans.
Transvaginal ultrasonography has become the primary method of assessment of the health of an early pregnancy.
In non-pregnant patients who are evaluated for RPL the following tests are usually performed. Parental chromosome testing (karyogram) is generally recommended after 2 or 3 pregnancy losses. Blood tests for thrombophilia, ovarian function, thyroid function and diabetes are performed.
If the likely cause of recurrent pregnancy loss can be determined treatment is to be directed accordingly. In patients with unexplained RPL chances are about 60-70% that the next pregnancy is successful without treatment. In certain chromosomal situations, while treatment may not be available, IVF with preimplantation genetic diagnosis may be able to identify embryos with a reducedrisk of another pregnancy loss which than would be transferred. Close survaillence during pregnancy is generally recommended for pregnant patients with a history of recurrent pregnancy loss. Even with appropriate and correct treatment another pregnancy loss may occur as each pregnancy develops its own risks and problems.
- Christiansen OB, et al: Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005;83:821-9.
- Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ 2004;329:1283-5. PMID 15564263.
- ^ Royal College of Obstetricians and Gynaecologists - The Investigation and Treatment of Couple with Recurrent Miscarriage Guideline No 17 PDF document
- ^ ACOG Practice Bulletin: Management of Early Pregnancy Loss. Number 24, February 2001.
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|